Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller, AB Heimberger - Neuro-oncology, 2015 - academic.oup.com
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller, AB Heimberger - Neuro-Oncology, 2015 - zora.uzh.ch
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
[PDF][PDF] Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller, AB Heimberger - 2015 - researchgate.net
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
Immunosuppressive mechanisms in glioblastoma.
EK Nduom, M Weller, AB Heimberger - Neuro-oncology, 2015 - sonar.ch
English Despite maximal surgical and medical therapy, the treatment of glioblastoma
remains a seriously vexing problem, with median survival well under 2 years and few long …
remains a seriously vexing problem, with median survival well under 2 years and few long …
[HTML][HTML] Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller, AB Heimberger - Neuro-Oncology, 2015 - ncbi.nlm.nih.gov
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
Immunosuppressive mechanisms in glioblastoma
EK Nduom - Neuro-Oncology, 2015 - doc.rero.ch
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
[PDF][PDF] Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller, AB Heimberger - 2015 - core.ac.uk
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
Immunosuppressive mechanisms in glioblastoma
EK Nduom, M Weller… - Neuro …, 2015 - mdanderson.elsevierpure.com
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a
seriously vexing problem, with median survival well under 2 years and few long-term …
seriously vexing problem, with median survival well under 2 years and few long-term …
Immunosuppressive mechanisms in glioblastoma.
EK Nduom, M Weller, AB Heimberger - Neuro-oncology, 2015 - folia.unifr.ch
English Despite maximal surgical and medical therapy, the treatment of glioblastoma
remains a seriously vexing problem, with median survival well under 2 years and few long …
remains a seriously vexing problem, with median survival well under 2 years and few long …
[引用][C] Immunosuppressive mechanisms in glioblastoma: Fig. 1.
EK Nduom, M Weller, AB Heimberger - Neuro-Oncology, 2015 - cir.nii.ac.jp